Related Experiment Video
Updated: Oct 15, 2025

05:41
Hand Dissection of Caenorhabditis elegans Intestines
Published on: September 13, 2022
3.6K
NGLY1: insights from Caenorhabditis elegans
1Basic Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
Journal of Biochemistry
|October 26, 2021
Summary
Peptide:N-glycanase (NGLY1) deficiency causes developmental disorders. Studies in C. elegans reveal NGLY1 regulates proteasome function by editing the SKN-1A/Nrf1 transcription factor, offering insights for potential treatments.
Area of Science:
- Biochemistry
- Genetics
- Molecular Biology
Background:
- Peptide:N-glycanase (NGLY1) is a conserved enzyme removing N-linked glycans from cytosolic glycoproteins.
- Mutations in NGLY1 cause NGLY1 deficiency, a multisystem disorder impacting development, cognition, and motor control.
Purpose of the Study:
- To review insights into peptide:N-glycanase biology using Caenorhabditis elegans as a model system.
- To explore the role of NGLY1 in regulating the proteasome via the SKN-1A/Nrf1 transcription factor.
Main Methods:
- Utilized the genetic model organism Caenorhabditis elegans.
- Reviewed studies on peptide:N-glycanase function and substrate identification.
- Focused on the post-translational modification and activation mechanism of SKN-1A/Nrf1.
Main Results:
- Identified SKN-1A/Nrf1, an N-glycosylated transcription factor, as a critical substrate of peptide:N-glycanase.
- Demonstrated that NGLY1-dependent 'sequence editing' activates SKN-1A/Nrf1.
- Highlighted the importance of this mechanism for proteasome regulation.
Conclusions:
- NGLY1 plays a crucial role in regulating proteasome function through SKN-1A/Nrf1 'sequence editing'.
- Understanding these mechanisms in C. elegans provides valuable insights into NGLY1 deficiency.
- Findings pave the way for developing therapeutic strategies for NGLY1 deficiency.

